Tezspire (Tezepelumab)

Tezspire is a medicine for severe asthma and for nasal polyps that keep coming back. It is given as a shot under the skin once a month. It works by blocking an early alarm signal in the airways that starts swelling.

Brand names:Tezspire
Medication

What people taking Tezspire (Tezepelumab) report

Every report comes from a Lived member, sent anonymously.

Have you tried Tezspire (Tezepelumab) for Asthma?

NameHow it went

About Tezspire (Tezepelumab)

What It's For

Tezepelumab, sold as Tezspire, is a prescription injection for people 12 and older with severe asthma. It is an add-on maintenance treatment: it is used alongside existing inhalers and other controller medicines to prevent asthma attacks over time, not to relieve breathing trouble once an attack has started. In the main studies, it was given to people whose asthma kept flaring despite regular inhaled steroids plus at least one other controller medicine. Tezspire is also approved, again for people 12 and older, as an add-on treatment for chronic rhinosinusitis with nasal polyps. This is a long-lasting sinus condition in which soft, noncancerous growths form inside the nose and sinuses, causing congestion, facial pressure and a reduced sense of smell. Tezspire is used when the condition is not well controlled with standard care such as steroid nasal sprays. Tezspire is a monoclonal antibody, a lab-made protein designed to attach to one specific target in the body. Several other antibody medicines are used for severe asthma, and many work best in people with high levels of eosinophils, a type of white blood cell linked to allergic-type airway inflammation. In studies, Tezspire reduced asthma attacks whether a person's eosinophil levels were high or low.

How It Works

The cells that line the airways and the inside of the nose make a signaling protein called TSLP (thymic stromal lymphopoietin). TSLP acts near the start of the chain of events that leads to inflammation, prompting many kinds of immune cells to release substances that swell and narrow the airways in asthma and feed polyp growth in the sinuses. People with asthma and nasal polyps have higher levels of TSLP in the affected tissue. Tezepelumab attaches to TSLP and stops it from reaching its receptor. Because TSLP sits so early in the process, blocking it lowers several downstream signs of inflammation at once, including eosinophils, IgE (the antibody involved in allergies) and FeNO, a breath test that reflects inflammation in the airways. Researchers have not fully worked out how these changes translate into fewer asthma attacks and smaller polyps.

Dosage & Administration

Tezspire is injected under the skin once every four weeks. Everyone it is approved for receives the same dose (210 mg), so there is no gradual dose increase at the start. It is added to existing treatment rather than replacing it. It comes as a single-dose vial or prefilled syringe, which a healthcare professional gives in the clinic, and as a prefilled pen, which people or caregivers can use at home once they have been trained and the prescriber agrees it is appropriate. The injection goes into the thigh or abdomen, avoiding about 2 inches around the navel, or into the upper arm when someone else gives it. Rotating the site with each dose is recommended. Tezspire is stored in the refrigerator and left out for about an hour to reach room temperature before injecting; it should not be shaken or warmed. If needed, it can be kept at room temperature for up to 30 days, but once it has warmed up it should not go back into the refrigerator. If a dose is missed, it is given as soon as possible and the usual schedule then continues.

Side Effects

Most people tolerate Tezspire well. In the asthma studies, sore throat, joint pain and back pain were slightly more common than with placebo injections. In the nasal polyp study, colds and other upper respiratory infections, sore throat, nosebleeds, back pain, flu and injection site reactions (redness, swelling or pain where the shot was given) were more frequent than with placebo. Allergic reactions can happen, usually within hours of an injection but sometimes days later. A rash, hives or red, itchy eyes after a dose should be reported to the care team promptly. Serious allergic reactions (anaphylaxis) have been reported since the drug came to market: trouble breathing, swelling of the face, lips, tongue or throat, or fainting or feeling faint after a dose needs emergency care, so call 911.

Interactions & Warnings

Tezspire does not treat an asthma attack that is already happening. A rescue inhaler and an action plan for sudden symptoms are still needed, and asthma that stays uncontrolled or gets worse after starting Tezspire is a reason to contact the prescriber. Do not stop or cut down inhaled or oral steroids on your own when starting Tezspire. If a lower steroid dose becomes possible, it should be reduced gradually under a doctor's supervision. Lowering steroid tablets too quickly can cause withdrawal symptoms and can bring back conditions the steroids had been keeping in check. Live vaccines, which contain a weakened form of a virus or bacterium, should be avoided during treatment, so mention Tezspire to anyone offering a vaccine. TSLP may help the body fight parasitic worm infections, so an existing worm infection is treated before starting. Anyone who has had an allergic reaction to Tezspire should not use it. No formal drug interaction studies have been done. In a follow-on study lasting up to two years, serious heart-related problems were reported more often with Tezspire than with placebo (about 1 versus 0.2 for every 100 people treated for a year). The types of heart problems varied, and rates of heart attack, stroke and cardiovascular death were not clearly different between the groups. People with heart disease may want to weigh this with their doctor. There is no information on Tezspire in human pregnancy. Antibody medicines like it cross the placenta more in the third trimester, but poorly controlled asthma also carries risks for both mother and baby, so pregnancy plans are worth discussing early. Whether it passes into human breast milk is not known.

What to Expect

Tezspire is a long-term preventive treatment. In the main asthma study, people who received it for a year had less than half as many serious asthma attacks as those given placebo (about 0.9 versus 2.1 a year), and attacks needing an emergency visit or a hospital stay fell by about four fifths. Lung function, measured as how much air a person can blow out in one second (FEV1), improved modestly, with changes seen as early as two weeks. Because attacks come and go, judging whether Tezspire is working usually means tracking attacks, symptoms, rescue inhaler use and breathing tests over several months. In a study designed to test whether it could replace daily steroid tablets, it did not significantly reduce the steroid dose people needed, so it should not be assumed to make those tablets unnecessary. For nasal polyps, a year of treatment shrank polyps, as seen on endoscopy (a camera exam inside the nose), and eased nasal congestion more than placebo. For either condition, treatment usually continues as long as it is helping, and the prescriber decides how long based on the response.

Questions to Ask Your Doctor

  1. 1.Why is Tezspire a good fit for my asthma or nasal polyps compared with other antibody treatments?
  2. 2.How will we tell whether it is working, and when will we review that?
  3. 3.Could I eventually lower my steroid inhaler or tablets, and how would we do that safely?
  4. 4.Can I learn to inject it at home, and what should I do if I notice a reaction after a dose?
  5. 5.Do I need any vaccines before starting, and how should we plan if I want to become pregnant?

Last reviewed • Oct 2026

Educational content, not medical advice.